OCULAR THERAPEUTIX, INC short interest in 2024
In 2024, OCULAR THERAPEUTIX, INC's disclosed short interest ran from 4.21% of shares outstanding on 12 Jan 2024 to 6.83% on 31 Dec 2024, a change of +2.62 percentage points. The year's high was 15.73% on 14 Jun 2024 and its low 4.21% on 12 Jan 2024, averaging 9.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.43 days on 13 Sep 2024. Full history: OCULAR THERAPEUTIX, INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 4.21% (12 Jan 2024)
- End of year
- 6.83% (31 Dec 2024)
- Change
- +2.62 pp
- High
- 15.73% (14 Jun 2024)
- Low
- 4.21% (12 Jan 2024)
- Average
- 9.73%
- Highest days to cover
- 25.43 (13 Sep 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 4.21% | 2.54 | |
| 31 Jan 2024 | 4.99% | 3.01 | |
| 15 Feb 2024 | 4.99% | 2.52 | |
| 29 Feb 2024 | 5.97% | 1.25 | results (8-K) |
| 15 Mar 2024 | 6.17% | 2.96 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 7.94% | 8.06 | |
| 15 Apr 2024 | 9.85% | 10.52 | |
| 30 Apr 2024 | 14.18% | 5.66 | |
| 15 May 2024 | 14.28% | 7.02 | 10-Q filed, results (8-K) |
| 31 May 2024 | 15.12% | 11.82 | |
| 14 Jun 2024 | 15.73% | 11.20 | |
| 28 Jun 2024 | 14.36% | 5.79 | |
| 15 Jul 2024 | 13.71% | 11.98 | |
| 31 Jul 2024 | 12.84% | 15.15 | |
| 15 Aug 2024 | 12.04% | 15.63 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 11.77% | 23.33 | |
| 13 Sep 2024 | 11.20% | 25.43 | |
| 30 Sep 2024 | 10.39% | 10.66 | |
| 15 Oct 2024 | 8.51% | 8.00 | |
| 31 Oct 2024 | 8.13% | 13.43 | |
| 15 Nov 2024 | 6.85% | 11.37 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 6.78% | 10.53 | |
| 13 Dec 2024 | 6.66% | 12.89 | |
| 31 Dec 2024 | 6.83% | 12.69 |
See also: OCULAR THERAPEUTIX, INC's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.